Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
78
datasets available to search
ShareScore release 0.9.0
Dataset results
78 results for “HCC recurrence”
Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
ClinicalTrials.gov study NCT01640808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Liver Stiffness by Ultrasound Elastography for Predicting Early HCC Recurrence After Treatment
ClinicalTrials.gov study NCT04552236. IPD Sharing: Not stated. Countries: 0. Publications: 11.
Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation
ClinicalTrials.gov study NCT06799468. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Unique MicroRNA Expression Signature Predicts Survival, Metastases and Recurrence of HCC
GEO Series GSE6857. Mus musculus; Homo sapiens. 482 samples. Type: Non-coding RNA profiling by array.
Expression profiling of HCC patients with different recurrent-free survival time
GEO Series GSE11260. Homo sapiens. 32 samples. Type: Expression profiling by array.
Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive HCC
GEO Series GSE17856. Homo sapiens. 95 samples. Type: Expression profiling by array.
Combined Treatment of RFA and Sorafenib on Recurrent HCC
ClinicalTrials.gov study NCT01470495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
ClinicalTrials.gov study NCT05352646. IPD Sharing: YES. Countries: 1. Publications: 0.
Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion
ClinicalTrials.gov study NCT02728219. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation
ClinicalTrials.gov study NCT03839706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non Transplantable Recurrence After Percutaneous Thermal Ablation of HCC
ClinicalTrials.gov study NCT05202184. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection
ClinicalTrials.gov study NCT03839550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
ClinicalTrials.gov study NCT04639180. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC
ClinicalTrials.gov study NCT03313648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alectinib in Combination with Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided with Serum RNase1 and Tumor Expression of PD-L1
ClinicalTrials.gov study NCT06354387. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation
ClinicalTrials.gov study NCT04564313. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC
ClinicalTrials.gov study NCT00375661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Deep Learning Model for the Prediction of Post-LT HCC Recurrence
ClinicalTrials.gov study NCT05200195. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) Versus Camrelizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection
ClinicalTrials.gov study NCT05367687. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
ClinicalTrials.gov study NCT07337460. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.